127 related articles for article (PubMed ID: 10076726)
1. Bone marrow scintigraphy using technetium-99m antigranulocyte antibody in malignant lymphomas.
Krause T; Eisenmann N; Reinhardt M; Bathmann J; Altehoefer C; Finke J; Moser E
Ann Oncol; 1999 Jan; 10(1):79-85. PubMed ID: 10076726
[TBL] [Abstract][Full Text] [Related]
2. Comparative diagnostic accuracy of magnetic resonance imaging and immunoscintigraphy for detection of bone marrow involvement in patients with malignant lymphoma.
Altehoefer C; Blum U; Bathmann J; Wüstenberg C; Uhrmeister P; Laubenberger J; Lange W; Schwarzkopf J; Moser E; Langer M
J Clin Oncol; 1997 May; 15(5):1754-60. PubMed ID: 9164182
[TBL] [Abstract][Full Text] [Related]
3. 18-F-fluorodeoxyglucose-positron emission tomography as a new approach to detect lymphomatous bone marrow.
Moog F; Bangerter M; Kotzerke J; Guhlmann A; Frickhofen N; Reske SN
J Clin Oncol; 1998 Feb; 16(2):603-9. PubMed ID: 9469348
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow scintigraphy with 99m Tc labelled monoclonal anti-NCA 90 Fab' fragment: a feasibility study and comparison of bone marrow uptake with 99m Tc labelled monoclonal anti-NCA 95 antigranulocyte antibody.
Ivancevic V; Huic D; Wolter A; Munz DL
Nucl Med Commun; 2002 Mar; 23(3):249-55. PubMed ID: 11891483
[TBL] [Abstract][Full Text] [Related]
5. Immunoscintigraphy of the bone marrow: normal uptake values of technetium-99m-labeled monoclonal antigranulocyte antibodies.
Huić D; Ivancević V; Richter WS; Munz DL
J Nucl Med; 1997 Nov; 38(11):1755-8. PubMed ID: 9374347
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow disease detection with FDG-PET/CT and bone marrow biopsy during the staging of malignant lymphoma: results from a large multicentre study.
Pelosi E; Penna D; Douroukas A; Bellò M; Amati A; Arena V; Passera R; Bisi G
Q J Nucl Med Mol Imaging; 2011 Aug; 55(4):469-75. PubMed ID: 21150862
[TBL] [Abstract][Full Text] [Related]
7. Tc-99m labelled anti CD 66 antigranulocyte antibody imaging for assessment of bone marrow reserve.
Matthies A; Reinhardt M; Palmedo H; Ezziddin S; Abramowski B; Kuhn W; Biersack HJ; von Mallek D
Cancer Invest; 2005; 23(2):119-22. PubMed ID: 15813503
[TBL] [Abstract][Full Text] [Related]
8. Improved diagnosis of advanced bone marrow metastases by means of radiolabeled antigranulocyte antibodies.
von Mallek D; Joe A; Palmedo H; Matthies A; Biersack HJ; Reinhardt MJ
J Exp Clin Cancer Res; 2002 Sep; 21(3):421-4. PubMed ID: 12385588
[TBL] [Abstract][Full Text] [Related]
9. FDG-PET in the detection of bone marrow disease in Hodgkin's disease and aggressive non-Hodgkin's lymphoma and its impact on clinical management.
Pelosi E; Penna D; Deandreis D; Chiappella A; Skanjeti A; Vitolo U; Bisi G
Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):9-16. PubMed ID: 18235420
[TBL] [Abstract][Full Text] [Related]
10. Chronic post-traumatic osteomyelitis of the lower extremity: comparison of magnetic resonance imaging and combined bone scintigraphy/immunoscintigraphy with radiolabelled monoclonal antigranulocyte antibodies.
Kaim A; Ledermann HP; Bongartz G; Messmer P; Müller-Brand J; Steinbrich W
Skeletal Radiol; 2000 Jul; 29(7):378-86. PubMed ID: 10963422
[TBL] [Abstract][Full Text] [Related]
11. [Bone marrow scintigraphy and magnetic resonance tomography in malignant lymphomas: comparison with histologic results].
Linden A; Zankovich R; Theissen P; Schauerte G; Diehl V; Schicha H
Nuklearmedizin; 1989 Oct; 28(5):166-71. PubMed ID: 2813080
[TBL] [Abstract][Full Text] [Related]
12. Can Positron Emission Tomography and Computed Tomography Be a Substitute for Bone Marrow Biopsy in Detection of Bone Marrow Involvement in Patients with Hodgkin's or Non-Hodgkin's Lymphoma?
Çetin G; Çıkrıkçıoğlu MA; Özkan T; Karatoprak C; Ar MC; Eşkazan AE; Ayer M; Cerit A; Gözübenli K; Uysal BB; Erdem S; Ergül N; Tatar G; Çermik TF
Turk J Haematol; 2015 Sep; 32(3):213-9. PubMed ID: 25912844
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow scintigraphy using technetium-99m-antigranulocyte antibody in hematologic disorders.
Chung JK; Yeo J; Lee DS; Park S; Lee MC; Kim BK; Koh CS
J Nucl Med; 1996 Jun; 37(6):978-82. PubMed ID: 8683326
[TBL] [Abstract][Full Text] [Related]
14. Malignant lymphoma: bone marrow imaging versus biopsy.
Linden A; Zankovich R; Theissen P; Diehl V; Schicha H
Radiology; 1989 Nov; 173(2):335-9. PubMed ID: 2678249
[TBL] [Abstract][Full Text] [Related]
15. Positron emission tomography (PET) for staging low-grade non-Hodgkin's lymphomas (NHL).
Najjar F; Hustinx R; Jerusalem G; Fillet G; Rigo P
Cancer Biother Radiopharm; 2001 Aug; 16(4):297-304. PubMed ID: 11603000
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow immunoscintigraphy using technetium-99m anti-granulocyte antibody in multiple myeloma.
Sohn SK; Ahn BC; Lee SW; Kim DH; Chun KA; Kim JG; Park SH; Song HS; Lee B; Lee J
Eur J Nucl Med Mol Imaging; 2002 May; 29(5):591-6. PubMed ID: 11976796
[TBL] [Abstract][Full Text] [Related]
17. Initial clinical results with technetium-99m-labeled LL2 monoclonal antibody fragment in the radioimmunodetection of B-cell lymphomas.
Baum RP; Niesen A; Hertel A; Adams S; Kojouharoff G; Goldenberg DM; Hör G
Cancer; 1994 Feb; 73(3 Suppl):896-9. PubMed ID: 8306276
[TBL] [Abstract][Full Text] [Related]
18. Comparison of technetium-99m tetrofosmin and gallium-67 citrate scintigraphy for detecting malignant lymphoma.
Yang CC; Sun SS; Lin CC; Kao CH; Lee CC
Anticancer Res; 2001; 21(5):3695-8. PubMed ID: 11848545
[TBL] [Abstract][Full Text] [Related]
19. Dichotomy between Tc-99m MDP bone scan and fluorine-18 fluorodeoxyglucose coincidence detection positron emission tomography in patients with non-Hodgkin's lymphoma.
Lee J; Park CH; Kim HC; Kim HS
Clin Nucl Med; 2000 Jul; 25(7):532-5. PubMed ID: 10885695
[TBL] [Abstract][Full Text] [Related]
20. Photopenic lesions in bone marrow scintigraphy using technetium-99m labeled antigranulocyte antibody without known tumour.
Krause T; Reinhardt M; Nitzsche E; Moser E
Nuklearmedizin; 1999 Apr; 38(3):85-9. PubMed ID: 10320994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]